Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.

Br J Dermatol

Division of Infectious Diseases and Global Public Health, Department of Medicine.

Published: August 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111668PMC
http://dx.doi.org/10.1111/bjd.21240DOI Listing

Publication Analysis

Top Keywords

evaluating risk
4
risk bullous
4
bullous pemphigoid
4
pemphigoid mrna
4
mrna covid-19
4
covid-19 vaccination
4
evaluating
1
bullous
1
pemphigoid
1
mrna
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!